Temsirolimus and bevacizumab, or sunitinib, or interferon alfa and bevacizumab for patients with advanced renal cell carcinoma (TORAVA): a randomised phase 2 trial

✍ Scribed by Sylvie Négrier; Gwenaëlle Gravis; David Pérol; Christine Chevreau; Rémy Delva; Jacques-Olivier Bay; Ellen Blanc; Céline Ferlay; Lionnel Geoffrois; Frédéric Rolland; Eric Legouffe; Emmanuel Sevin; Brigitte Laguerre; Bernard Escudier

• Book ID: 117785671
• Publisher: The Lancet
• Year: 2011
• Tongue: English
• Weight: 236 KB
• Volume: 12
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/s1470-2045(11)70124-3